Institut Sainte Catherine;Recherche Clinique

Avignon 84918

0 studies enrolling now · 2 studies all time

What they study most

Bladder Cancer, Carcinoma, Transitional Cell

Studies at this site

• A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection — Stopped early
• A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] — Completed